Jon P. Stonehouse - 12 Dec 2025 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Chief Executive Officer, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
12 Dec 2025
Net transactions value
-$207,176
Form type
4
Filing time
16 Dec 2025, 16:09:05 UTC
Previous filing
13 Nov 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stonehouse Jon P Chief Executive Officer, Director 4505 EMPEROR BLVD., SUITE 200, DURHAM /s/ Alane P. Barnes, by power of attorney 16 Dec 2025 0001385496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Tax liability $207,176 -27,368 -1.9% $7.57 1,405,222 12 Dec 2025 Direct F1
holding BCRX Common Stock 30,000 12 Dec 2025 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding BCRX Common Stock 30,000 12 Dec 2025 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.